[1] 张恒亮,张培,姚亚丽.不同病因所致心力衰竭的预后分析[J].心脏杂志,2013,25(6):668-671.
[2] 张卫庆,郭祥.倍他乐克对风湿性心脏瓣膜病心衰患者的长期疗效观察[J].现代诊断与治疗,2012,23(7):997-998.
[3] 刘凤岐,傅世英,修春红,等.上胸段硬膜外阻滞对扩张型心肌病心腔及收缩功能的影响[J].中华麻醉学杂志,2001,21(3):178-179.
[4] LI Q S,LIU F Q L.Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure[J].J Cardiothorac Surg,2013,8(22):2953-2968.
[5] 李舒,刘凤歧,马丹,等.心区交感神经阻滞对慢性心力衰竭患者左室重构及心功能的影响[J].中国超声医学杂志,2015,31(7):596-598.
[6] 杨杰孚.2014年中国心力衰竭诊断和治疗指南新亮点(慢性心衰)[R].中国南方国际心血管病学术会议论文集,2014,8-9.
[7] 罗征祥.心脏瓣膜病治疗的发展[J].岭南心血管病杂志,2010,16:343-351.
[8] FUKUYAMA H,ISHIDA T,TAHIBANA H,et al.Validation of scoring systems for prediting severe ommunity-acquired pneumonia[J].Intern Med,2011,50(18):1917-1922.
[9] RICHARDS A M,DOUGHTY R,NICHOLLS M G,et al.Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin:prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction.Australia-New Zealand Heart Failure Group[J].J Am Coll Cardiol,2001,37(7):1781-1787.
[10] 李方平,叶剑,朱宇熹.倍他乐克缓释片治疗慢性充血性心力衰竭时B型钠尿肽的变化[J].现代医学,2013,41(6):401-403.
[11] 薄小萍,李明秋,陈茂华,等.重组人脑利钠肽治疗急性心梗后失代偿性心力衰竭的疗效观察[J].东南大学学报:医学版,2012,31(1):93-96.
[12] 查芳芳.脑钠肽对血液透析患者心功能不全的临床诊断意义[J].现代医学,2011,39(3):293-295.
[13] 修春红,刘凤岐,王怀全,等.超声评价心区交感神经阻滞对扩张型心肌病右心腔径及功能的影响[J].中国超声医学杂志,2006,22:505-507.
[14] WU S,FU S Y,LIU F Q,et al.Use of a high thoracic epidural analgesia for treatment of end-stagecongestive heart failure secondary to coronary artery disease Effect of HTEA on CHF International[J].J Cardiol,125(2008):283-285. |